[ad_1] (RxWiki News) Artificial sweeteners may raise your risk of a host of health problems, according to a new study. Stevioside (Stevia), sucralose and aspartame appeared to increase the long-term
Diabetes Across the US | RxWiki
[ad_1] (RxWiki News) More than 100 million adults across the United States are living with diabetes or prediabetes, according to a new report from the Centers for Disease Control and
Opioid Prescriptions: A Persistent Problem
[ad_1] (RxWiki News) Despite an overall decline in the number of opioids prescribed during the last nine years, the amount remained high, according to a new report. This report, recently
Your Work Hours Might Affect Your Heart
[ad_1] (RxWiki News) Staying late at the office might affect your heart health, according to a new study. In this study of more than 85,000 European workers, it appeared those
New Breast Cancer Rx Class Gets Good Review
[ad_1] (RxWiki News) A new class of breast cancer medications appeared to have manageable side effects for most patients, according to a new study. Most patients with hormone receptor-positive (HR+)
New Hepatitis Rx Approved | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new medication to treat hepatitis. The new approval is for Vosevi, which is a tablet that contains
Why Some Stroke Survivors Skip Their Statins
[ad_1] (RxWiki News) Concerns over side effects may cause some stroke survivors to not take the statins they’re prescribed, a new study found. That may mean that some patients are
Is Prostate Cancer Surgery Recommended For Everyone?
[ad_1] (RxWiki News) For some men with prostate cancer, surgery may not be more beneficial than observation, according to a new study. The surgery could even cause side effects like
Choosing the Right Depression Rx
[ad_1] (RxWiki News) Taking an antipsychotic medication may be more effective than switching to another antidepressant in treating depression, a new study found. Patients who began taking aripiprazole in addition
New Rx May Keep Breast Cancer Away
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a medication meant to prevent breast cancer from returning. The FDA approved Nerlynx (neratinib) to lower the risk